Samsung Electronics Co., Ltd.

C&c Research Laboratories

Sung Oh Ahn

Chang Ho Shin

Seok Chan Hong

Won Il Lee

Sun Young Han

Chan Hee Park

Kwang Seok Ko

Soon Ok Lee

Hye Jung Kim

In Je Sung

Jun Hwan Im

Pil Su Ho

Jin Se Kim

Jung Sook Kim

Seong Wook Cho

Kyoung June Lee

Woul Seong Park

Dong Oh Yoon

A light emitting module includes a circuit board having a plurality of reflective portions arranged in one direction and connection portions connecting the plurality of reflective portions, light emitting devices mounted on the plurality of reflective portions, and lens units disposed to cover the light emitting devices within boundaries of surfaces, of the plurality of reflective portions, on which the light emitting devices are mounted. A width of each of the connection portions in the other direction, perpendicular to the one direction thereof, is smaller than a diameter of each of the lens units, thus reducing a generation of a dark portion.

Light emitting module and lighting device using the same

The present invention relates to novel heterocyclic compounds of formula 1 useful in preparing drugs for treatment of diseases associated with various functions of the histamine 4 receptor. Especially, the said drugs are useful for treatment of inflammatory diseases, allergy, pain, nasal polyps, rhinitis, chronic sinusitis, nasal congestion, nasal itch, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria, idiopathic chronic urticaria, scleroderma, conjunctivitis, keratoconjunctivitis, ocular inflammation, dry eye, cardiac dysfunction, arrhythmia, atherosclerosis, multiple sclerosis, inflammatory bowel disease (including colitis, Crohn's disease, ulcerative colitis), inflammatory pain, neuropathic pain, osteoarthritic pain, autoimmune thyroid disease, immune-mediated (also known as type I) diabetes, lupus, post-operative adhesions, vestibular disorders and cancer. 

Substituted tricyclic heterocycles as histamine 4 receptor inhibitors

A light source module includes: a substrate; and a plurality of light emitting devices having different ranks and arranged on the substrate in columns and rows, the plurality of light emitting devices being classified in the different ranks based on at least one of color coordinates, brightness of light emitted therefrom and a driving voltage, wherein in at least one of the columns and rows, light emitting devices having different ranks from among the plurality of light emitting devices are alternated in a basic arrangement and are alternated in an inverse arrangement opposite to the basic arrangement.

Light source module and backlight unit

The present application provides an electronic apparatus including a substrate including a first electrode pad, a second electrode pad and an intermediate pad each disposed on one surface of the substrate and separated from one another. An electronic device is disposed on the substrate and including a first electrode unit and a second electrode unit. The first electrode unit has an adhesion surface facing the first electrode pad and the intermediate pad. The second electrode unit has an adhesion surface facing the second electrode pad.

Electronic apparatus

Disclosed are heterocyclic derivatives, and more particularly heterocyclic derivatives having the following Formula I which are useful for the preparation of medicaments for treating diseases related to uric acid: wherein R, R, R, R, R, R, R, R, X, X, X, L and Y are the same as defined in the detailed description.

Heterocyclic derivatives

Growing community of inventors

Suwon, South Korea

Sung Oh Ahn